Objective-To determine the effect ofnocturnal hypoglycaemia on sleep architecture in adolescents with insulin dependent diabetes mellitus (IDDM). Design-20 adolescents with IDDM (mean age 12.8 years, mean glycated haemoglobin (HbA1) 8.9%) were studied on one night. Plasma glucose was measured every 30 minutes and cortisol and growth hormone levels every 60 minutes. Sleep was recorded using standard polysomnographic montages, and sleep architecture was analysed for total sleep time, stages 1-4, rapid eye movement, fragmentation, and arousals.
globin (HbA1) 8 .9%) were studied on one night. Plasma glucose was measured every 30 minutes and cortisol and growth hormone levels every 60 minutes. Sleep was recorded using standard polysomnographic montages, and sleep architecture was analysed for total sleep time, stages 1-4, rapid eye movement, fragmentation, and arousals.
Results-Six subjects (30%) became hypoglycaemic (five subjects < 2.5 mmolIl), with one being symptomatic. There were no differences in age, HbAlc, duration of diabetes, or insulin regimen between hypoglycaemic and non-hypoglycaemic subjects. Hypoglycaemia was not predicted by glucose measurements before bed. There was no detectable rise in plasma cortisol or growth hormone concentrations during hypoglycaemia. Sleep architecture was not disturbed by nocturnal hypoglycaemia with no differences found in sleep stages, fragmentation, or arousals.
Conclusions-Nocturnal hypoglycaemia is a common and usually asymptomatic complication of treatment in adolescents with IDDM. Moderate hypoglycaemia has not been shown to affect sleep architecture adversely. These findings are consistent with, and may explain, the observation that severe hypoglycaemia, with consequent seizure activity, is more common at night than during the day. Counterregulatory hormone responses to nocturnal hypoglycaemia may be less marked than with similar degrees of diurnal hypoglycaemia.
(Arch Dis Child 1996;75:120-123) Keywords There were no significant differences in total output (as measured hourly), peak level, or maximum increment of increase of plasma cortisol or growth hormone between the two groups (table 3). The expected early morning rise in plasma cortisol was observed in all patients. Growth hormone concentrations varied markedly, both between individuals and in the same individual, and were unrelated to glycaemic levels.
SYMPTOMS AND CLINICAL MEASUREMENTS
One child reported subjective symptoms of hypoglycaemia (hunger) at a plasma glucose concentration of 2.1 mmolIl.
Heart rates were recorded continuously during the study and expressed in 30 second averages. There were no rises in heart rate during hypoglycaemia in any child. In four of the children who became hypoglycaemic, the heart rates were lower at the nadir of the plasma glucose concentrations than during preceding euglycaemia (mean fall 9.25 beats/min). The remaining two hypoglycaemic children's heart rates remained stable.
Porter, Byrne, Stick, Jones HbA,cconcentrations in the subjects studied are similar to the clinic average for this age. In view of the finding that hypoglycaemia was mostly asymptomatic, even at plasma glucose levels of < 2.5 mmol/l, the frequency of hypoglycaemia determined by recording symptomatology alone may an underestimate of the true incidence, reports of hypoglycaemia in children that rely on subjective information provided by parents or on the incidence of coma being unreliable. 6 Shalwitz et ar reported a high frequency of nocturnal hypoglycaemia occurring at 0200 h, with 14.4% of the values being below 3.3 mmol/l, while Whincup and Milner reported 34% below 3.0 mmolIl.9 Our findings confirm this incidence. Although it is possible that hospital admission may increase the incidence of hypoglycaemia, we endeavoured to minimise this possibility by admitting the subjects as late as possible and ensuring a normal day's activity and exercise. In studies where children were admitted for 48 hours, adjustment cannot be made for differences in dietary intake or exercise and as such do not increase the validity of the study. We were unable to find any reliable predictive measures for subsequent nocturnal hypoglycaemia. Shalwitz et al showed that subsequent hypoglycaemia may be predicted by a 2200 h plasma glucose concentration of less than 5.6 mmol/l, a finding supported by Whincup and Milner, who determined that a plasma glucose of 7 mmol/l was the best predictor. examine more subtle changes such as restlessness. The lack of any adverse effect on sleep during hypoglycaemia is reassuring in that such episodes would not be expected to result in daytime somnolence. On the other hand the lack of symptomatology with moderate hypoglycaemia might result in the patient failing to arouse and intervene appropriately to prevent more severe nocturnal hypoglycaemia.
To examine the counter-regulatory hormonal response to hypoglycaemia we measured plasma cortisol, growth hormone, and heart rates (as an indirect measure of adrenergic stimulation). The lack of a measurable hormonal counter-regulatory response to blood glucose concentrations of less than 3 mmol/l is surprising. Jones et al studied adolescents with and without diabetes and found increases in adrenaline and cortisol at this level in diabetic and non-diabetic subjects.2"22 Similarly, hypoglycaemic symptom scores rose in the diabetic subjects at blood glucose concentrations below 4.2 mmol/l.22 Whether these differences are due to methodology (that is, hyperinsulinaemic clamp induced versus 'spontaneous' hypoglycaemia) or to differences in responses to diurnal and nocturnal hypoglycaemia is open to speculation. Alternatively the lack of a hormonal response may be explained by recent work showing that hypoglycaemia per se will decrease the response to subsequent hypoglycaemia.'0 It is conceivable that those children who became hypoglycaemic during the study had been hypoglycaemic in the 24 hours before the start and may have been relatively unresponsive to further stress.
In summary, nocturnal hypoglycaemia is a common and usually asymptomatic complication of treatment in adolescents with IDDM. Moderate hypoglycaemia has not been shown to affect sleep architecture adversely. This may explain why severe hypoglycaemia and subsequent seizures are more common at night than during the day. Finally, questions have been raised as to possible differences in hormonal counter-regulation to diurnal and nocturnal hypoglycaemia in this group.
